TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86 February 6, 1987
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Diet-Nutrition Grant Guidelines: NIH Says They’re CREGS, Gori Says They’re Not April 9, 1976
